JNJ News Alert Johnson & Johnson (JNJ) 104.59 12/25/2014 18:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Johnson & Johnson (JNJ) 104.59 $JNJ

Don't Worry About Missing The Bottom
Eli Inkrot - at Seeking Alpha - Thu Dec 25, 1:41PM CST

KMI: 42.01 (+0.10), JNJ: 104.59 (+0.31), GE: 25.83 (-0.05), PG: 93.14 (-0.15), AFL: 61.94 (unch)

Final Glance: Pharmaceuticals companies
AP - Wed Dec 24, 5:02PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 104.59 (+0.31), BAX: 74.45 (-0.04), PFE: 31.42 (-0.03), BMY: 59.15 (-0.01)

Final Glance: Medical Devices companies
AP - Wed Dec 24, 5:02PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 114.11 (+0.64), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), BAX: 74.45 (-0.04)

Integra LifeSciences Hits 52-Week High on Portfolio Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 12:00PM CST
Over the last few months, Integra LifeSciences Holdings Corporation (IART) has launched back-to-back products which we believe will enhance the overall product portfolio and also usher in more profitability for the company.
ZMH: 114.11 (+0.64), JNJ: 104.59 (+0.31), IART: 53.68 (+0.32), SYK: 96.00 (-0.61)

Early Glance: Pharmaceuticals companies
AP - Wed Dec 24, 9:23AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are up at 10 a.m.:
JNJ: 104.59 (+0.31), BAX: 74.45 (-0.04), PFE: 31.42 (-0.03), BMY: 59.15 (-0.01)

Early Glance: Medical Devices companies
AP - Wed Dec 24, 9:23AM CST
NEW YORK (AP) — Shares of some top medical devices companies are up at 10 a.m.:
ZMH: 114.11 (+0.64), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), BAX: 74.45 (-0.04)

The Hepatitis C Drug Developer That Crushed Gilead Sciences, Inc. in 2014 (Hint: It's Not AbbVie)
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 24, 8:03AM CST
For shareholders of Gilead Sciences it's practically been a dream year . Shares rose close to 40%, tacking on roughly $45 billion in market value, following the successful approval and launch of oral hepatitis C drugs Sovaldi and Harvoni. ...
JNJ: 104.59 (+0.31), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), ABBV: 66.21 (+1.86), BMY: 59.15 (-0.01), ENTA: 49.04 (+0.06)

4 Reasons I'm Adding Gilead To My Healthcare Holdings
Brian Nichols - at Seeking Alpha - Wed Dec 24, 6:18AM CST

JNJ: 104.59 (+0.31), ACAD: 30.95 (+0.78), GILD: 91.29 (+1.84), CLDX: 17.08 (-0.18)

Use of Composites in Orthopedic Industry to Reach $596 Million by 2020
PR Newswire Europe - Wed Dec 24, 3:57AM CST
NEW YORK and LONDON, December 24, 2014 /PRNewswire/ --
SNN: 38.18 (+0.14), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), NUVA: 47.37 (+0.78), SYK: 96.00 (-0.61)

Pharmacyclics Reveals FDA Action Date for Imbruvica sNDA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 5:05PM CST
Pharmacyclics, Inc. (PCYC) announced that the FDA is expected to render a final opinion on the supplemental New Drug Application for Imbruvica for WM indication by Apr 17, 2015.
AGN: 210.12 (+0.95), JNJ: 104.59 (+0.31), ACT: 254.20 (-1.68), PCYC: 121.84 (+1.15)

Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 4:00PM CST
Achillion Pharmaceuticals (ACHN) gained more than 9% after announcing encouraging results from its HCV candidates.
JNJ: 104.59 (+0.31), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), AMGN: 160.67 (+3.15)

Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 3:50PM CST
Pharmacy benefit manager Express Scripts (ESRX) announced an update to its National Preferred Formulary, which will now include AbbVie's (ABBV) recently approved new medication for hepatitis C, Viekira Pak.
JNJ: 104.59 (+0.31), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86), CRL: 63.59 (+0.33)

AbbVie Puts The Hurt On Gilead Sciences, Closes Exclusive Deal With Express Scripts
Kal Telage - at Seeking Alpha - Tue Dec 23, 3:41PM CST

JNJ: 104.59 (+0.31), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86)

Johnson & Johnson Set to Possibly Rebound After Yesterday's Selloff of 2.30%
Comtex SmarTrend(R) - Tue Dec 23, 3:41PM CST
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $103.92 to a high of $106.91. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $104.74 on volume of 10.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JNJ: 104.59 (+0.31)

Look for Shares of Johnson & Johnson to Potentially Rebound after Yesterday's 2.30% Sell Off
Comtex SmarTrend(R) - Tue Dec 23, 3:40PM CST
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $103.92 to a high of $106.91. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $104.74 on volume of 10.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JNJ: 104.59 (+0.31)

My 10 Stocks For A Young Dividend Growth Investor
Integrator - at Seeking Alpha - Tue Dec 23, 2:02PM CST

SBUX: 81.27 (-0.16), JNJ: 104.59 (+0.31), V: 267.63 (+2.37), HSY: 106.28 (-0.36), DIS: 94.42 (-0.27), COST: 143.65 (-0.50), COP: 70.13 (-0.92), VZ: 47.67 (unch), PEP: 97.09 (-0.27), CL: 70.47 (-0.53)

MacroGenics Inks Deal with J&J for Blood Cancer Therapy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 2:00PM CST
MacroGenics, Inc. (MGNX) entered into a collaboration and license agreement with Johnson & Johnson for the development and commercialization of MGD011.
MGNX: 33.00 (+0.34), JNJ: 104.59 (+0.31), MDCO: 27.06 (+0.21), BMY: 59.15 (-0.01), FPRX: 26.12 (+0.07)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cognex Delivers Record Q3 Results, Eyes Future Growth

Updated Category News Views 62

Shaking Up the Leaderboard with Record Revenues You want a testament to a well-oiled machine? Look no further than Cognex Corporation, flaunting a record quarterly revenue hitting $313 million. That's a hearty 13% uptick from last year. Peel back the layers, and excluding a one-time boon from a partnership last year, you're staring at a 19% year-over-year surge. Talk...

Continue Reading
REELZ Gears Up for 75th Miss Universe Pageant

Updated Category News Views 123

A Global Celebration Comes to REELZ Let's dive straight into the glitz and spectacle—REELZ isn't just broadcasting some regular program. They're handing us the 75th Miss Universe pageant on a silver (or maybe gold, in this case) platter. Come November 24, at 8 PM ET, expect your screen to light up with beauty, culture, and a hefty dose of competition, as it unfolds live...

Continue Reading
Texas Alcohol Crash Stats Expose Reckless Drinking Scene

Updated Category News Views 54

Staggering Numbers From Texas Crashes Reveal a Sobering Truth When you peel back the layers on Texas's latest alcohol-related crash data, you're looking at a grim picture painted by Grossman Law Offices. In a state that's no stranger to big numbers and even bigger drinks, finding that half of these crashes had a blood alcohol content (BAC) over twice the legal limit makes...

Continue Reading
Kyndryl and AWS Shake Up Enterprise Modernization

Updated Category News Views 87

A New Dawn for Enterprise Modernization Modernizing enterprise infrastructure today ain't just about wading through outdated code lines. Kyndryl (NYSE: KD) is flipping the script, with their latest partnership with Amazon Web Services (AWS) aiming to make modernization swift, continuous, and AI-ready. Gone are the days of treating technology upgrades as a one-off event....

Continue Reading
Sae-A Trading Earns UNGC LEAD Recognition Again

Updated Category News Views 44

Another Year, Another Win for Sae-A Trading When was the last time you heard of an apparel manufacturer making waves for the right reasons? Sae-A Trading, the outfit under the Global Sae-A Group banner, is strutting its sustainability stuff by getting named as a UNGC LEAD Company for the second straight year. You better believe that’s not just for show – they’ve got...

Continue Reading
Taiwan's Bold Bid: From Tech Hub to Capital Magnet

Updated Category News Views 100

Ambitious Plans Unveiled at Taiwan Weeks 2026 Forget the usual humdrum; Taiwan’s pulling no punches in its bid to become a capital powerhouse in Asia. If you'd told me years ago that Taiwan was eyeing dominance in asset management, I might've laughed. But at the 2026 Taiwan Weeks, they showed they're dead serious about it. Over 400 bigwigs and market shakers gathered,...

Continue Reading
RingConn Joins BVB Women's Team: Tech Meets Sport

Updated Category News Views 64

Tech and Football: An Unlikely Alliance Alright, so here's a story that might perk your ears up—RingConn, a relative newcomer in the health tech world, has chosen to stake its future on a bet with Borussia Dortmund's women's football team. This isn't just your average brand-sponsorship slap-on-the-shirt deal; we're looking at a potential game-changer here, folks. Who...

Continue Reading
Elite Academy Takes Bold Step in Ethical AI for Schools

Updated Category News Views 171

Pioneering New Fronts in Education with AI Elite Academic Academy, a stalwart in California's public charter school landscape, has just taken a significant stride forward by stepping into the EDSAFE AI Alliance District Policy Lab. The move, announced in early November 2026, sees Elite diving into the intricate world of artificial intelligence in education, with a pointed...

Continue Reading
Perpetua's Bold Moves Elevate Idaho's Stibnite Gold Project

Updated Category News Views 91

Perpetua Resources Sparking New Conversations Alright, fasten your seatbelts, folks—Perpetua Resources is causing a buzz with its Stibnite Gold Project. If you blink, you might miss what's happening down in Idaho. They've started throwing some serious weight around with fresh gold discoveries that not only promise ounces but maybe some juicy returns for those keeping a...

Continue Reading
What Business Owners Need to Know About Glass Replacement

Updated Category News Views 114

Understanding the Nuts and Bolts of Storefront Glass Replacement Picture your storefront beaten and battered, glass cracks spidering over once-pristine panes. Cue Matt Sears of Bentonville Glass Inc. ready to patch things up without turning your business into a disaster zone. The homegrown hero makes his debut in HelloNation's latest chat, offering the kind of advice you...

Continue Reading

Top 5 Most Recently Viewed Articles

Piramal Pharma and NewAmsterdam's Joint Venture for OSD Suite

Updated Category News Views 161

Strategic Investment to Boost Pharmaceutical Production Piramal Pharma Solutions and NewAmsterdam Pharma Company N.V. have embarked on an ambitious project to enhance their oral solid dosage (OSD) capabilities. This new dedication to pharmaceutical manufacturing illustrates their commitment to meeting rising healthcare demands. The multi-million-dollar investment seeks to...

Continue Reading
Dynacor Group Announces Upcoming Dividend and Insights

Updated Category News Views 140

Dynacor Group Announces Upcoming Dividend Dynacor Group Inc. (TSX: DNG) has declared its monthly dividend for October, an essential aspect for shareholders. The company will distribute C$0.01333 per common share, with payment scheduled for October 16 to those holding shares by the close of business on October 9. This marks the 67th dividend the corporation has provided....

Continue Reading
Danske Bank's Buy-Back Program: Week 2 Summary and Insights

Updated Category News Views 181

Danske Bank's Buy-Back Program Overview Danske Bank A/S has initiated an impressive share buy-back program aimed at enhancing shareholder value. This program, set for a total of DKK 5.5 billion, encompasses the repurchase of up to 70 million shares. It commenced on February 5, 2024, and is designated to conclude by January 31, 2025. This substantial commitment was...

Continue Reading
Howmet Aerospace: A Promising Investment Journey Over Five Years

Updated Category News Views 192

Howmet Aerospace's Investment Potential Howmet Aerospace (NYSE: HWM) has shown remarkable performance, significantly exceeding market averages over the past five years. Investors who have been with the company through this period are likely quite satisfied with their returns. The annualized return of 51.59% speaks volumes about the company's strategic growth and...

Continue Reading
Recent Updates on Investment Fund Wealth Invest's Prospectuses

Updated Category News Views 614

Updates on Wealth Invest Prospectuses We are pleased to announce the recent updates to the prospectuses for the listed departments within the investment fund Wealth Invest. These changes reflect the fund's commitment to maintaining transparency and enhancing investor confidence. Reason for Updates The prospectuses have undergone revisions primarily due to a name change...

Continue Reading